| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Bakr Hameed, Md Rizwanullah, Showkat Rasool Mir, M Shaheer Akhtar, Saima Ami. Development of cannabidiol nanoemulsion for direct nose to brain delivery: Statistical optimization, in vitro and in vivo evaluation. Biomedical materials (Bristol, England). 2022-09-15. PMID:36108625. |
cannabidiol (cbd) is a prescribed drug for epilepsy but has low oral bioavailability and gastric instability. |
2022-09-15 |
2023-08-14 |
Not clear |
| Se Hee Kim, Han Som Choi, Chung Mo Koo, Bong-Rim Joo, Byung-Joo Park, Hae Kook Lee, Joon Soo Lee, Heung Dong Kim, Hoon-Chul Kan. Effects of Cannabidiol on Adaptive Behavior and Quality of Life in Pediatric Patients With Treatment-Resistant Epilepsy. Journal of clinical neurology (Seoul, Korea). vol 18. issue 5. 2022-09-05. PMID:36062772. |
effects of cannabidiol on adaptive behavior and quality of life in pediatric patients with treatment-resistant epilepsy. |
2022-09-05 |
2023-08-14 |
Not clear |
| Chander Singh, Komal Rao, Nikita Yadav, Yogesh Vashist, Palak Chugh, Nidhi Bansal, Neha Minoch. Current Cannabidiol Safety: A Review. Current drug safety. 2022-09-03. PMID:36056846. |
cannabidiol has been confirmed as an efficient treatment of epilepsy in several clinical trials, with one pure cbd product named epidiolex. |
2022-09-03 |
2023-08-14 |
Not clear |
| Alfredo Cerisola, Lucía Cibils, María Eugenia Chaibún, Virginia Pedemonte, Melania Rosa. [Tuberous sclerosis complex: diagnosis and current treatment]. Medicina. vol 82 Suppl 3. 2022-09-02. PMID:36054862. |
recently, many therapeutic strategies have developed, including preventive treatment of epilepsy, new options for treatment of epilepsy as cannabidiol, mtor inhibitors, ketogenic diet, and a more precise epilepsy surgery. |
2022-09-02 |
2023-08-14 |
Not clear |
| Michal Tzadok, Nasrin Hamed, Gali Heimer, Efrat Zohar-Dayan, Shira Rabinowicz, Bruria Ben Zee. The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy. Pediatric neurology. vol 136. 2022-09-01. PMID:36049378. |
several retrospective studies on pediatric epilepsy reported positive effects of cannabidiol-enriched artisanal cannabis oil and pure cannabidiol oil on seizure reduction. |
2022-09-01 |
2023-08-14 |
Not clear |
| Nathan T Cohen, Burak Bahar, Joan A Conry, John M Schreibe. Variability in Serum Concentrations and Clinical Response in Artisanal Versus Pharmaceutical Cannabidiol Treatment of Pediatric Pharmacoresistant Epilepsy. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. vol 27. issue 6. 2022-08-31. PMID:36042959. |
variability in serum concentrations and clinical response in artisanal versus pharmaceutical cannabidiol treatment of pediatric pharmacoresistant epilepsy. |
2022-08-31 |
2023-08-14 |
Not clear |
| Zsolt Gáll, Krisztina Kelemen, Andrea Tolokán, István Zolcseak, István Sável, Réka Bod, Elek Ferencz, Szende Vancea, Melinda Urkon, Melinda Kolcsá. Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines. vol 10. issue 8. 2022-08-26. PMID:36009358. |
anticonvulsant action and long-term effects of chronic cannabidiol treatment in the rat pentylenetetrazole-kindling model of epilepsy. |
2022-08-26 |
2023-08-14 |
rat |
| Zsolt Gáll, Krisztina Kelemen, Andrea Tolokán, István Zolcseak, István Sável, Réka Bod, Elek Ferencz, Szende Vancea, Melinda Urkon, Melinda Kolcsá. Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines. vol 10. issue 8. 2022-08-26. PMID:36009358. |
cannabidiol (cbd) showed anticonvulsant action in several preclinical models and is currently approved by regulatory agencies to treat childhood epilepsy syndromes. |
2022-08-26 |
2023-08-14 |
rat |
| Carlos André Oshiro, Luiz Henrique Martins Castr. Cannabidiol and epilepsy in Brazil: a current review. Arquivos de neuro-psiquiatria. vol 80. issue 5 Suppl 1. 2022-08-17. PMID:35976327. |
cannabidiol and epilepsy in brazil: a current review. |
2022-08-17 |
2023-08-14 |
Not clear |
| Carlos André Oshiro, Luiz Henrique Martins Castr. Cannabidiol and epilepsy in Brazil: a current review. Arquivos de neuro-psiquiatria. vol 80. issue 5 Suppl 1. 2022-08-17. PMID:35976327. |
cannabidiol (cbd) has become a promising therapeutic option in the treatment of epilepsy. |
2022-08-17 |
2023-08-14 |
Not clear |
| Monsicha Ngampoopun, Charcrin Nabangchang, Piradee Suwanpakde. Survey of local cannabidiol use in parents of children with epilepsy in Thailand: the prevalence, perceptions, and knowledge. Journal of cannabis research. vol 4. issue 1. 2022-07-26. PMID:35883129. |
survey of local cannabidiol use in parents of children with epilepsy in thailand: the prevalence, perceptions, and knowledge. |
2022-07-26 |
2023-08-14 |
Not clear |
| Monsicha Ngampoopun, Charcrin Nabangchang, Piradee Suwanpakde. Survey of local cannabidiol use in parents of children with epilepsy in Thailand: the prevalence, perceptions, and knowledge. Journal of cannabis research. vol 4. issue 1. 2022-07-26. PMID:35883129. |
in 2019, thailand legalized cannabidiol (cbd) for intractable epilepsy. |
2022-07-26 |
2023-08-14 |
Not clear |
| Gabriela Araujo Moreira, Roddie Moraes Neto, Ricardo Gullit Ribeiro, Ana Chrystina De Souza Cripp. Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature. Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo. vol 41. 2022-07-13. PMID:35830160. |
cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature. |
2022-07-13 |
2023-08-14 |
Not clear |
| Gabriela Araujo Moreira, Roddie Moraes Neto, Ricardo Gullit Ribeiro, Ana Chrystina De Souza Cripp. Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature. Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo. vol 41. 2022-07-13. PMID:35830160. |
the aim of this current report was to present a critical review of the use of cannabidiol (cbd) in the treatment of refractory epilepsies in the pediatric population. |
2022-07-13 |
2023-08-14 |
Not clear |
| Terence J O'Brien, Samuel F Berkovic, Jacqueline A French, John A Messenheimer, Terri B Sebree, Marcel O Bonn-Miller, Donna L Gutterma. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial. JAMA network open. vol 5. issue 7. 2022-07-08. PMID:35802375. |
adjunctive transdermal cannabidiol for adults with focal epilepsy: a randomized clinical trial. |
2022-07-08 |
2023-08-14 |
Not clear |
| Terence J O'Brien, Samuel F Berkovic, Jacqueline A French, John A Messenheimer, Terri B Sebree, Marcel O Bonn-Miller, Donna L Gutterma. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial. JAMA network open. vol 5. issue 7. 2022-07-08. PMID:35802375. |
cannabidiol has shown efficacy in randomized clinical trials for drug-resistant epilepsy in specific syndromes that predominantly affect children. |
2022-07-08 |
2023-08-14 |
Not clear |
| Terence J O'Brien, Samuel F Berkovic, Jacqueline A French, John A Messenheimer, Terri B Sebree, Marcel O Bonn-Miller, Donna L Gutterma. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial. JAMA network open. vol 5. issue 7. 2022-07-08. PMID:35802375. |
however, high-level evidence for the efficacy and safety of cannabidiol in the most common form of drug-resistant epilepsy in adults, focal epilepsy, is lacking. |
2022-07-08 |
2023-08-14 |
Not clear |
| b' Asra Tanwir, C \\xc3\\x81kos Szab\\xc3\\xb. Non-convulsive status epilepticus in the setting of cannabidiol adjunctive therapy. Epileptic disorders : international epilepsy journal with videotape. vol 24. issue 4. 2022-06-30. PMID:35770762.' |
we present a 63-year-old, right-handed male with a history of intractable focal epilepsy since age seven years old, whose bouts of ncse were triggered by cannabidiol (cbd) adjunctive therapy. |
2022-06-30 |
2023-08-14 |
Not clear |
| Carol J Milligan, Lyndsey L Anderson, Michael T Bowen, Samuel D Banister, Iain S McGregor, Jonathon C Arnold, Steven Petro. A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function. Journal of cannabis research. vol 4. issue 1. 2022-06-10. PMID:35689251. |
purified cannabidiol (cbd), a non-psychoactive phytocannabinoid, has gained regulatory approval to treat intractable childhood epilepsies. |
2022-06-10 |
2023-08-14 |
Not clear |
| Aaron Del Pozo, Leanne Lehmann, Kevin M Knox, Melissa Barker-Halisk. Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy. Frontiers in neurology. vol 13. 2022-05-16. PMID:35572927. |
for example, cannabidiol and fenfluramine demonstrated clear efficacy in syndrome-specific pediatric models that led to a paradigm shift in the perceived value of pediatric models for asm discovery practice; aged rodents with seizures or rodents with aging-related neuropathology represent an untapped resource that could similarly change epilepsy drug discovery. |
2022-05-16 |
2023-08-13 |
Not clear |